Skip to main content

People in the News: Transgenomic Hires Two New VPs; Worland Joins GenMark Board

Premium

Transgenomic has appointed Matthew Beer as vice president of business development for oncology; and John McAuliffe as vice president of business development for neurology.

Beer was previously director of oncology marketing and hematology/oncology life cycle leader at Quest Diagnostics. Prior to that, he was vice president of business development at Caris Life Sciences. He has also worked for Abbott, Targeted Molecular Diagnostics, and Oncotech. He holds a BS in microbiology from the University of Iowa.

McAuliffe previously worked at HistoRx, where he served as vice president of sales. Prior to that, he was director of business development at Athena Diagnostics. McAuliffe holds a BS in pharmacolopgy from the University of California, Santa Barbara.


GenMark Diagnostics said this week that Stephen Worland has been appointed to its board of directors.

Worland is currently president and CEO of Effector Therapeutics. He was president and CEO and a director of Anadys Pharmaceuticals from 2007 until the company was acquired by Roche in 2011. Worland joined Anadys in 2001 and served in a number of executive roles prior to being named CEO, including president of pharmaceuticals and chief scientific officer. He began his healthcare industry career in 1988 at Agouron Pharmaceuticals.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.